Adverse Reactions to Isosulfan Blue During Selective Sentinel Lymph Node Dissection in Melanoma
Received: 23 September 1999 Accepted: 03 January 2000 DOI:
10.1007/s10434-000-0361-x Cite this article as: Leong, S.P.L., Donegan, E., Heffernon, W. et al. Ann Surg Oncol (2000) 7: 361. doi:10.1007/s10434-000-0361-x Abstract Background: Selective sentinel lymph node (SLN) dissection can spare about 80% of patients with primary melanoma from radical lymph node dissection. This procedure identifies the SLN either visually by injecting isosulfan blue dye around the primary melanoma site or by handheld gamma probe after radiocolloid injection. Methods: During selective SLN mapping, 1 to 5 ml of isosulfan blue was injected intradermally around the primary melanoma. From November 1993, to August 1998, 406 patients underwent intraoperative lymphatic mapping with the use of both isosulfan blue and radiocolloid injection. Three cases of selective SLN dissection, in which adverse reactions to isosulfan blue occurred, were reviewed. Results: We report three cases of anaphylaxis after intradermal injection with isosulfan blue of 406 patients who underwent intraoperative lymphatic mapping by using the procedure as described above. The three cases we report vary in severity from treatable hypotension with urticaria and erythema to severe cardiovascular collapse with or without bronchospasm or urticaria. Conclusions: In our series, the incidence of anaphylaxis to isosulfan blue was approximately 1%. Anaphylaxis can be fatal if not recognized and treated rapidly. Operating room personnel who participate in intraoperative lymphatic mapping where isosulfan blue is used must be aware of the potential consequences and be prepared to treat anaphylaxis. Keywords Anaphylaxis Isosulfan blue Melanoma SLN REFERENCES
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.
Alex J, Krag D. Gamma-probe-guided localization of lymph nodes. Surg Oncol 1993;2:137–44.
Leong SPL. The role of sentinel lymph node in human solid cancer. In: Devita VT, Hellman S, Rosenberg SA, eds. PPO Updates, vol 12. Philadelphia: Lippincott-Raven, 1998.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941–6.
Burke TW, Levenback C, Tornos C, et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169–73.
Johnson LW, Sehon J, Li BD. Potential utility of sentinel node biopsy in the original surgical assessment of He‘urthle cell tumors of the thyroid: 23-year institutional review of He‘urthle cell neoplasms. J Surg Oncol 1999;70:100–2.
Little AG, DeHoyos A, Kirgan DM, et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999;117:220–34.
Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol 1998;124:790–3.
Terada KY, Coel MN, Ko P, Wong JH. Combined use of intraoperative lymphatic mapping and lymphoscintigraphy in the management of squamous cell cancer of the vulva. Gynecol Oncol 1998;70:65–9.
Joosten JJ, Strobbe LJ, Wauters CA, et al. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482–6.
Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666–73.
Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217–24.
Fisher M, Baldo BA. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 1994;11:263–84.
Toh KW, Deacock SJ, Fawcett WJ. Severe anaphylactic reaction to cisatracurium. Anesth Analg 1999;88:462–4.
Ewan PW. Anaphylaxis [published erratum appears in BMJ 1998;316:1507]. BMJ 1998;316:1442–5.
Moss J. Adverse drug reactions caused by histamine. Refresh Courses Anesthesiol 1992;20:155–68.
Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991;324:1785–90.
Wyatt R. Anaphylaxis: how to recognize, treat and prevent potentially fatal attacks. Postgrad Med 1996;100:87–99.
Gueant JL, Aimone-Gastin I, Namour F, et al. Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy 1998;28(Suppl 4):65–70.
Konno R, Nagase S. Anaphylactic reaction to cefazolin in pregnancy. Obstet Gynecol 1995;21:577–9.
Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987;107:204–15.
Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992;152:930–7.
Pumphrey RSH, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999;353:1157–8.
Pepys J, Pepys EO, Baldo BA, Whitwam JG. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents: skin prick tests in aetiological diagnosis. Anaesthesia 1994;49:470–5.
Laroche D, Vergnaud MC, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs: comparison of plasma histamine and tryptase. Anesthesiology 1991;75:945–9.
Quiliquini A, Hogendijk S, Hauser C. Anaphylaxis to patent blue [letter]. Dermatology 1998;197:400.
Kopp WL. Anaphylaxis from alphazurine 2G during lymphography. JAMA 1966;198:668–9.
Hietala SO, Hirsch JI, Faunce HF. Allergic reaction to patent blue violet during lymphography. Lymphology 1977;10:158–60.
Barber CJ. Serious adverse reaction to patent blue violet at lymphography. Clin Radiol 1989;40:631.
Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharmacy 1985;4:219–21.
Koehler P. Complications and accidents. In: Ruttman A, ed. Progress in Lymphology: Proceedings of the International Symposium on Lymphography. Zurich: Stuttgart, Georg Thieme Verlag, 1967, 306–8.
Coleman RL, Whitten CW, O’Boyle J, Sidhu B. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol 1999;70:126–9.
Larsen VH, Freudendal-Pedersen A, Fogh-Andersen N. The influence of patent blue V on pulse oximetry and haemoximetry. Acta Anaesthesiol Scand Suppl 1995;107:53–5.
Saito S, Fukura H, Shimada H, Fujita T. Prolonged interference of blue dye “patent blue” with pulse oximetry readings. Acta Anaesthesiol Scand 1995;39:268–9.
Giuliano AE. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;350:958.
PubMed Copyright information
© The Society of Surgical Oncology, Inc. 2000